BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2288308)

  • 1. [Diffusion of cefmenoxime into prostatic fluid in the patients with acute bacterial prostatitis].
    Katoh N; Sugiyama T; Ono Y; Hirabayashi S
    Hinyokika Kiyo; 1990 Nov; 36(11):1287-93. PubMed ID: 2288308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion of cefmenoxime and latamoxef into prostatic fluid in the patients with acute bacterial prostatitis.
    Katoh N; Ono Y; Ohshima S; Miyake K
    Urol Int; 1992; 48(2):191-4. PubMed ID: 1585513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the prostatic tissue levels of cefmenoxime (CMX)].
    Kataoka K; Kaneko S; Kurita T
    Hinyokika Kiyo; 1985 Feb; 31(2):273-9. PubMed ID: 2409786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of a new injectable cephem, FK037, for acute bacterial prostatitis].
    Suzuki K; Horiba M; Ishikawa K; Katoh S
    Hinyokika Kiyo; 1994 Dec; 40(12):1131-7. PubMed ID: 7863869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal of subcategorization of bacterial prostatitis: NIH category I and II diseases can be further subcategorized on analysis by therapeutic and immunological procedures.
    Naide Y; Ishikawa K; Tanaka T; Ando S; Suzuki K; Hoshinaga K
    Int J Urol; 2006 Jul; 13(7):939-46. PubMed ID: 16882059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential changes in the prostatic fluid level of latamoxef in patients with acute bacterial prostatitis.
    Itoh M; Katoh N; Ono Y; Ohshima S; Miyake K
    Urol Int; 1995; 55(2):101-4. PubMed ID: 8533190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on cefmenoxime (CMX) in urology].
    Tanaka H; Kato Y; Kakinoki K; Nishio S; Maekawa M; Tsujita M; Nishijima T; Kashihara N; Kono S; Hayahara N
    Hinyokika Kiyo; 1983 Jan; 29(1):95-103. PubMed ID: 6328956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the concentration of cefminox sodium in serum and prostatic tissue].
    Sasagawa I
    Hinyokika Kiyo; 1990 Jun; 36(6):737-9. PubMed ID: 1700586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic and clinical studies on cefmenoxime in neonates and infants].
    Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M; Taneda Y; Inokuma K; Ozaki T; Ichikawa T; Matsui S
    Jpn J Antibiot; 1989 Dec; 42(12):2641-60. PubMed ID: 2614919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic tissue levels of ceftizoxime].
    Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
    Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
    Takao M; Matsuzaki S; Ao T; Nagakura K; Fujioka T; Hata M; Nakamura H; Hayakawa M
    Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of prostatic tissue levels of cefodizime (CDZM)].
    Yamada Y; Fukatsu H; Kamijo A; Mizumoto H; Taki T; Mitsui K; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y
    Hinyokika Kiyo; 1994 Apr; 40(4):365-9. PubMed ID: 7514846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic bacterial prostatitis: a review of treatment approaches.
    Kot T; Pettit-Young N
    Compr Ther; 1990 Aug; 16(8):54-9. PubMed ID: 2173653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic and clinical studies on cefmenoxime in newborn infants].
    Nakazawa S; Sato H; Hirama Y; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Nakanishi Y; Chikaoka H; Niino K
    Jpn J Antibiot; 1989 Dec; 42(12):2627-40. PubMed ID: 2614918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.